Colgate-Palmolive (CL) is a publicly traded Consumer Defensive sector company. As of May 20, 2026, CL trades at $90.33 with a market cap of $71.95B and a P/E ratio of 34.78. CL moved +0.43% today. Year to date, CL is +15.87%; over the trailing twelve months it is -1.87%. Its 52-week range spans $74.55 to $104.16. Analyst consensus is buy with an average price target of $96.00. Rallies surfaces CL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $90.33 |
| Market Cap | $71.95B |
| P/E Ratio | 34.78 |
| EPS | $2.60 |
| Dividend Yield | 0.53% |
| 52-Week High | $104.16 |
| 52-Week Low | $74.55 |
| Volume | 4.90M |
| Avg Volume | 0 |
| Revenue (TTM) | $20.80B |
| Net Income | $2.21B |
| Gross Margin | 60.06% |
16 analysts cover CL: 0 strong buy, 11 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $96.00.